Type 2 Diabetes Increases Risk of 24 Cancers. See this week’s Item #1.
FDA Adds Risk for Severe Liver Injury to Orlistat Label. More information on FDA announcement is available on the agency’s website.
Type 2 Diabetes Increases Risk of 24 Cancers. See this week’s Item #1.
FDA Adds Risk for Severe Liver Injury to Orlistat Label. More information on FDA announcement is available on the agency’s website.
|
|
|
|